1-4 of 4
Mona Shafey, MD
Close
Sort by
Journal Articles

Phase I/II Study of Infusional Gemcitabine and High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation for Patients with Relapsed/Refractory Lymphoma: Interim Safety Analysis

Marta Davidson, MDPhD, Douglas A. Stewart, Peter Duggan, MD FRCPC, Andrew Daly, MD, Mona Shafey, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4534.
https://doi.org/10.1182/blood.V130.Suppl_1.4534.4534
Published: 2017
Journal Articles

BK Virus Hemorrhagic Cystitis Is Associated with Graft Versus Host Disease and Increased Health Care Resource Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation

Wilson Lam, MD, Jan Storek, MD PhD, Nizar J Bahlis, MD, Christopher Brown, MD, Peter Duggan, MD FRCPC, Michelle Geddes, MD FRCPC, Mary Lynn Savoie, MD FRCPC, Mona Shafey, MD FRCPC, Douglas A. Stewart, MD FRCPC, Andrew Daly, MD FRCPC
Journal: Blood
Blood (2014) 124 (21): 3901.
https://doi.org/10.1182/blood.V124.21.3901.3901
Published: 2014
Journal Articles

Prolonged Survival in Secondary CNS Lymphoma Following High Dose Thiotepa/Busulfan-Based Chemotherapy (HDTB) and Autologous Stem Cell Transplantation (ASCT): Single Institution Results From Calgary, Canada

Lesley E. Street, MD, FRCPC, Nizar J. Bahlis, MD, Karen Valentine, MD, PhD, Deirdre A. Jenkins, MD, FRCPC, Carolyn J Owen, MD, FRCPC, Mona Shafey, MD, FRCPC, Peter Duggan, MD, FRCPC, Douglas A. Stewart, MD, FRCPC
Journal: Blood
Blood (2012) 120 (21): 2003.
https://doi.org/10.1182/blood.V120.21.2003.2003
Published: 2012
Journal Articles

Preference of Patients and Physicians Concerning Treatment Options for Relapsed Follicular Lymphoma: A Discrete Choice Experiment.

Mona Shafey, MD, FRCPC, Douglas A. Stewart, MD, FRCPC, Thuan Do, MD, FRCPC, Sasha Lupichuk, MD, FRCPC
Journal: Blood
Blood (2009) 114 (22): 4350.
https://doi.org/10.1182/blood.V114.22.4350.4350
Published: 2009